[go: up one dir, main page]

FR2759906B1 - Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques - Google Patents

Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques

Info

Publication number
FR2759906B1
FR2759906B1 FR9702094A FR9702094A FR2759906B1 FR 2759906 B1 FR2759906 B1 FR 2759906B1 FR 9702094 A FR9702094 A FR 9702094A FR 9702094 A FR9702094 A FR 9702094A FR 2759906 B1 FR2759906 B1 FR 2759906B1
Authority
FR
France
Prior art keywords
milnacipran
medicament
derivatives
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9702094A
Other languages
English (en)
Other versions
FR2759906A1 (fr
Inventor
Michael Briley
Jean Francois Prost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR9702094A priority Critical patent/FR2759906B1/fr
Priority to AU64060/98A priority patent/AU6406098A/en
Priority to PCT/FR1998/000320 priority patent/WO1998036744A1/fr
Publication of FR2759906A1 publication Critical patent/FR2759906A1/fr
Application granted granted Critical
Publication of FR2759906B1 publication Critical patent/FR2759906B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FR9702094A 1997-02-21 1997-02-21 Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques Expired - Lifetime FR2759906B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9702094A FR2759906B1 (fr) 1997-02-21 1997-02-21 Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
AU64060/98A AU6406098A (en) 1997-02-21 1998-02-19 Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
PCT/FR1998/000320 WO1998036744A1 (fr) 1997-02-21 1998-02-19 Utilisation du milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702094A FR2759906B1 (fr) 1997-02-21 1997-02-21 Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques

Publications (2)

Publication Number Publication Date
FR2759906A1 FR2759906A1 (fr) 1998-08-28
FR2759906B1 true FR2759906B1 (fr) 2004-06-04

Family

ID=9504033

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9702094A Expired - Lifetime FR2759906B1 (fr) 1997-02-21 1997-02-21 Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques

Country Status (3)

Country Link
AU (1) AU6406098A (fr)
FR (1) FR2759906B1 (fr)
WO (1) WO1998036744A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US7345096B2 (en) * 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
PT1601349E (pt) * 2003-02-14 2008-10-27 Pf Medicament Utilização do enantiómero (1s, 2r) do milnaciprano para a preparação de um medicamento
FR2851163B1 (fr) 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
US20090203750A1 (en) * 2005-08-24 2009-08-13 Alan Kozikowski 5-HT2C Receptor Agonists as Anorectic Agents
JP2013510176A (ja) 2009-11-06 2013-03-21 ピエール ファーブル メディカモン （１ｓ，２ｒ）−２−（アミノメチル）−ｎ，ｎ−ジエチル−１−フェニルシクロプロパンカルボキサミドの新規結晶形態

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments
EP0792649A1 (fr) * 1996-02-29 1997-09-03 Eli Lilly And Company Traitement de l'insomnie

Also Published As

Publication number Publication date
FR2759906A1 (fr) 1998-08-28
AU6406098A (en) 1998-09-09
WO1998036744A1 (fr) 1998-08-27

Similar Documents

Publication Publication Date Title
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
ITMI951538A0 (it) Procedimento ed impianto per la disidratazione di foraggio particolarmente per la disidratazione dell'erba medica
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
FR2759906B1 (fr) Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
EP0990441A4 (fr) Medicament pour le traitement de la nephropathie diabetique
FR2758711B1 (fr) Dispositif d'extension continue et progressive de tissu vivant
FR2652747B1 (fr) Application d'agents actifs pour la preparation d'un medicament destine au traitement de maladies auto-immunes.
IT1291890B1 (it) Catetere per la diagnosi e il trattamento dell'eiaculazione precoce
MA26570A1 (fr) Forme active d'une proteine hedgehog, procede pour la produire, et son utilisation therapeutique
KR960009980U (ko) 여성용 생리대
KR960028334U (ko) 남성용 샤워기
FR2745719B1 (fr) Composition pour le traitement d'affections cutanees
KR960009978U (ko) 여성용 생리대
KR960009979U (ko) 여성용 생리대
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга
FR2734156B1 (fr) Dispositif d'hydrotherapie destine au massage du corps humain
UA917S (uk) Халат медичний жіночий

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 20